Price loading...

The 2023-2028 Outlook for Beta Interferon Therapeutics for Multiple Sclerosis in India

Price data last checked 105 day(s) ago - refreshing...

View at Amazon

Price History & Forecast

No Price Data Available

Price history will appear here once data is collected from Amazon.

Price Distribution

No price data available for histogram

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
14 September 2022
Listed Since
28 September 2022

Similar Products You Might Like

The 2023-2028 Outlook for Peripheral Neuritis Treatments in India
97% match

The 2023-2028 Outlook for Peripheral Neuritis Treatments in India

£515.00 22 Jan 2026
The 2023-2028 Outlook for Guillain-Barre Syndrome Therapeutics in India
97% match

The 2023-2028 Outlook for Guillain-Barre Syndrome Therapeutics in India

£515.00 04 Feb 2026
The 2023-2028 Outlook for Advanced Therapy Medicinal Products in India
96% match

The 2023-2028 Outlook for Advanced Therapy Medicinal Products in India

£515.00 22 Jan 2026
The 2023-2028 Outlook for Insomnia Therapeutics in India
96% match

The 2023-2028 Outlook for Insomnia Therapeutics in India

£515.00 25 Jan 2026
The 2023-2028 Outlook for Anti-Inflammatory Scleroderma Drugs in India
96% match

The 2023-2028 Outlook for Anti-Inflammatory Scleroderma Drugs in India

£515.00 06 Feb 2026
The 2023-2028 Outlook for Anti-Malarial Drugs in India
96% match

The 2023-2028 Outlook for Anti-Malarial Drugs in India

£515.00 22 Jan 2026
The 2023-2028 Outlook for Myasthenia Gravis in India
96% match

The 2023-2028 Outlook for Myasthenia Gravis in India

£515.00 10 Feb 2026
The 2023-2028 Outlook for Natural Killer Cell Therapeutics in India
96% match

The 2023-2028 Outlook for Natural Killer Cell Therapeutics in India

£515.00 06 Feb 2026
The 2023-2028 Outlook for Amyloidosis Treatments in India
96% match

The 2023-2028 Outlook for Amyloidosis Treatments in India

£515.00 10 Dec 2025
The 2023-2028 Outlook for External Neurostimulation in India
96% match

The 2023-2028 Outlook for External Neurostimulation in India

£515.00 22 Jan 2026
The 2023-2028 Outlook for Anti-Viral Nucleotide Polymerase Inhibitor Drugs in India
96% match

The 2023-2028 Outlook for Anti-Viral Nucleotide Polymerase Inhibitor Drugs in India

£515.00 22 Jan 2026
The 2023-2028 Outlook for Neurostimulation Devices in India
96% match

The 2023-2028 Outlook for Neurostimulation Devices in India

£515.00 21 Jan 2026
The 2023-2028 Outlook for Myeloproliferative Disorder Drugs in India
96% match

The 2023-2028 Outlook for Myeloproliferative Disorder Drugs in India

£515.00 31 Jan 2026
The 2023-2028 Outlook for Anti-Inflammatory Lupus Drugs in India
96% match

The 2023-2028 Outlook for Anti-Inflammatory Lupus Drugs in India

£515.00 27 Jan 2026
The 2023-2028 Outlook for Topical Vitiligo Therapeutics in India
96% match

The 2023-2028 Outlook for Topical Vitiligo Therapeutics in India

£515.00 24 Jan 2026
The 2023-2028 Outlook for Digital Therapeutics Sales in India
96% match

The 2023-2028 Outlook for Digital Therapeutics Sales in India

£515.00 26 Jan 2026
The 2023-2028 Outlook for Sarcopenia Treatments in India
96% match

The 2023-2028 Outlook for Sarcopenia Treatments in India

£515.00 29 Jan 2026
The 2023-2028 Outlook for HIV and AIDS Therapeutics in India
96% match

The 2023-2028 Outlook for HIV and AIDS Therapeutics in India

£515.00 23 Jan 2026
The 2023-2028 Outlook for Pseudotumor Cerebri in India
96% match

The 2023-2028 Outlook for Pseudotumor Cerebri in India

£515.00 31 Jan 2026
The 2023-2028 Outlook for Glioblastoma Multiforme Drugs in India
96% match

The 2023-2028 Outlook for Glioblastoma Multiforme Drugs in India

£515.00 26 Jan 2026
The 2023-2028 Outlook for Erythropoietin Drugs in India
96% match

The 2023-2028 Outlook for Erythropoietin Drugs in India

£515.00 10 Dec 2025
The 2023-2028 Outlook for Diabetic Foot Ulcer Therapeutics in India
96% match

The 2023-2028 Outlook for Diabetic Foot Ulcer Therapeutics in India

£515.00 25 Jan 2026
The 2023-2028 Outlook for Exocrine Pancreatic Insufficiency Therapeutics in India
96% match

The 2023-2028 Outlook for Exocrine Pancreatic Insufficiency Therapeutics in India

£515.00 10 Dec 2025
The 2023-2028 Outlook for Motion Sickness Treatments in India
96% match

The 2023-2028 Outlook for Motion Sickness Treatments in India

£515.00 06 Feb 2026